Condition category
Mental and Behavioural Disorders
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status
Results overdue

Plain English Summary

Background and study aims
Individual Placement and Support (IPS) is a model of support which has been tested in secondary care settings (hospitals) for people with severe and enduring mental health conditions. The objective of IPS is to get people back to work as soon as possible and to support them in employment both occupationally and psychologically. This study will test the impact of the intervention (or programme) when applied to people with common mental health conditions. By integrating local employment support (IPS) and clinical support services provided by NHS’ Improving Access to Psychological Therapies (IAPT) among other community services and 'treatments as usual', we hope to demonstrate that significant savings can be achieved as well leading to improvements in the participants health and employment prospects. It has already been tested on a small group (500 employment and support assistance claimants with common mental health conditions) to check what worked and why from the perspectives of claimants, advisers, and providers as well as analysis of measures of distance travelled (including wellbeing, self-efficacy for work, and a clinical measure of mental health). The aim of this study is to assess the programme on a larger number of people and in the field.

Who can participate?
Mostly claimants of Employment and Support Allowance (ESA) although a proportion of Jobseekers’ allowance claimants who are experiencing common mental health conditions will also be included.

What does the study involve?
In each participating area, participants are randomly allocated to one of two groups: treatment and control. The treatment group receive IPS and the control group receive whichever pre-existing alternative type of support is deemed most appropriate (e.g. IAPT, medication, community support).

What are the possible benefits and risks of participating?
Possible benefits include improved mental health and employment. We do not anticipate any risks above what would be expected in daily life

Where is the study run from?
Three areas in the UK: West London, Blackpool and Northumberland.

When is the study starting and how long is it expected to run for?
September 2015 to December 2017

Who is funding the study?
HM Cabinet Office (UK)

Who is the main contact?
Ms Ní Chonaire

Trial website

Contact information



Primary contact

Ms Aisling Ní Chonaire


Contact details

33 Greycoat Street
Floor 3
United Kingdom

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Examining the effect of Individual Placement and Support for those receiving mental health support on employment and health outcomes.


Study hypothesis

Does an integrated employment and mental health support programme (the IPS model) increase the number of people ceasing to receive unemployment benefits and increase their health outcomes?

Ethics approval

London - City Road & Hampstead Research Ethics Committee, 05/02/2016, REC ref: 15/LO/2158

Study design

Randomised controlled trial (individual level)

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet


Mental health


1. The control condition will receive mental health treatment as usual e.g. Improving Access to Psychological Therapies (IAPT), medication, GP support.
2. The treatment group will receive mental health treatment as usual as well as Individual Placement and Support (IPS) which is an integrated employment support service.

Intervention type



Drug names

Primary outcome measure

The primary outcome measure will involve whether the individuals are off unemployment benefits at 3 and 6 months after entering the intervention. This will be collected via Department for Work and Pensions administrative data.

Secondary outcome measures

Secondary outcome measures will include sub sample analysis (e.g. those who are long-term unemployed, those with higher levels of mental health difficulties, gender effects). In addition, for a sub sample of participants we will use mental health as an outcome measure (using PHQ9 and GAD7). We will also include administrative data from HSCIC to measure proxy health outcomes (e.g. hospital admissions, prescriptions). For data collected administratively (i.e. demographics data and HSCIC data), these will be collected 3 and 6 months after entry into the trial.

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Participants will be required to be in receipt of unemployment benefits.
2. Participants will be required to score within the mild to severe categorisation of the Patient Health Questionnaire 9 and the Generalized Anxiety Disorder 7.

Participant type


Age group




Target number of participants

Blackpool 1500 (1000 in treatment group), North East : 2800 and West London 2250.

Participant exclusion criteria

There are no exclusion criteria.

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Blackpool Council

Trial participating centre

West London Alliance
W5 2HL

Trial participating centre

Northumberland County Council
NE61 2EF

Sponsor information


HM Cabinet Office

Sponsor details

70 Whitehall
United Kingdom

Sponsor type




Funder type


Funder name

Cabinet Office

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

We plan on publishing a policy report on our results in Summer 2018.

Intention to publish date


Participant level data

Not expected to be available

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

04/04/2016: Ethics approval information added, recruitment start date changed from 07/09/2015 to 31/07/2016.